Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Tanner

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Neuromuscular Disorders : NMD|March 4, 1999
Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patientsS M Tanner, V Schneider, N S Thomas, et al.
Endocrinology|September 1, 1980
Metabolic clearance rate of growth hormone during experimental-growth arrest and subsequent recovery in ratsH D Mosier, R A Jansons, C S Biggs, et al.
Pediatrics|July 1, 1982
Use of a glucose-controlled insulin infusion system in children and adolescents with insulin-dependent diabetesM P Golden, G L Myers, S M Tanner, et al.
Human Genetics|May 14, 1999
Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier motherS M Tanner, K H Orstavik, M Kristiansen, et al.
Oncogene|August 30, 2001
Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utilityM C Frühwald, M S O'Dorisio, Z Dai, et al.
European Journal of Human Genetics : EJHG|October 22, 1998
Genomic organization of the MTM1 gene implicated in X-linked myotubular myopathyJ Laporte, C Guiraud-Chaumeil, S M Tanner, et al.
Neuromuscular Disorders : NMD|August 6, 2003
X-inactivation patterns in carriers of X-linked myotubular myopathyM Kristiansen, G P Knudsen, S M Tanner, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogeneticsK Virtaneva, F A Wright, S M Tanner, et al.
Human Mutation|May 2, 2000
MTM1 mutations in X-linked myotubular myopathyJ Laporte, V Biancalana, S M Tanner, et al.
The Western Journal of Medicine|July 1, 1982
The value of artificial beta cell in the management of insulinomaL J Valenta, H Eisenberg, D R Miller, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Neuromuscular Disorders : NMD|March 4, 1999
Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patientsS M Tanner, V Schneider, N S Thomas, et al.
Endocrinology|September 1, 1980
Metabolic clearance rate of growth hormone during experimental-growth arrest and subsequent recovery in ratsH D Mosier, R A Jansons, C S Biggs, et al.
Pediatrics|July 1, 1982
Use of a glucose-controlled insulin infusion system in children and adolescents with insulin-dependent diabetesM P Golden, G L Myers, S M Tanner, et al.
Human Genetics|May 14, 1999
Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier motherS M Tanner, K H Orstavik, M Kristiansen, et al.
Oncogene|August 30, 2001
Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utilityM C Frühwald, M S O'Dorisio, Z Dai, et al.
European Journal of Human Genetics : EJHG|October 22, 1998
Genomic organization of the MTM1 gene implicated in X-linked myotubular myopathyJ Laporte, C Guiraud-Chaumeil, S M Tanner, et al.
Neuromuscular Disorders : NMD|August 6, 2003
X-inactivation patterns in carriers of X-linked myotubular myopathyM Kristiansen, G P Knudsen, S M Tanner, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogeneticsK Virtaneva, F A Wright, S M Tanner, et al.
Human Mutation|May 2, 2000
MTM1 mutations in X-linked myotubular myopathyJ Laporte, V Biancalana, S M Tanner, et al.
The Western Journal of Medicine|July 1, 1982
The value of artificial beta cell in the management of insulinomaL J Valenta, H Eisenberg, D R Miller, et al.
Pageof 3